Tag Archives: New England Medical Journal

Heart experts clash on Vytorin and cancer risk

Reuters is reporting that experts are clashing over the safety of the cholesterol drug Vytorin as full results from a controversial study were presented at Europe’s biggest medical congress. Researchers involved in the so-called SEAS study – highlights of which were … Continue reading

Posted in Cancer, General Health, Health Headlines, Heart Health, Men's Health, Woman's Health | Tagged , , | Comments Off on Heart experts clash on Vytorin and cancer risk